Stocks · Health care · Pharmaceutical Preparations

Equillium, Inc.

EQ Clue Score53
United States Fiscal year ends December CIK 0001746466 Results filed 13 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Stephen Connelly
5 Jun 2026
President and CSO
Sell
30,975
$2.94
$91.07K
Stephen Connelly
4 Jun 2026
President and CSO
Sell
200,000
$3.16
$632.76K
Jason A Keyes
29 Aug 2022
Chief Financial Officer
Sell indirect
7,000
$2.83
$19.81K
Jason A Keyes
6 Jun 2022
Chief Financial Officer
Sell indirect
5,000
$2.52
$12.60K
Jason A Keyes
4 Apr 2022
Chief Financial Officer
Sell indirect
8,000
$3.18
$25.44K
Jason A Keyes
1 Dec 2021
Chief Financial Officer
Sell indirect
5,000
$5.08
$25.40K
Jason A Keyes
27 Sep 2021
Chief Financial Officer
Sell indirect
8,000
$6.74
$53.92K
Jason A Keyes
27 Jul 2021
Chief Financial Officer
Sell indirect
5,000
$5.72
$28.59K
Jason A Keyes
26 May 2021
Chief Financial Officer
Sell indirect
5,000
$6.50
$32.48K
Stephen Connelly
28 Dec 2020
Chief Scientific Officer
Sell
25,000
$4.52
$113.05K
Jason A Keyes
23 Dec 2020
Chief Financial Officer
Sell indirect
8,000
$4.74
$37.91K
Stephen Connelly
28 Sep 2020
Chief Scientific Officer
Sell
25,000
$5.62
$140.40K
Stephen Connelly
13 Jul 2020
Chief Scientific Officer
Sell
250,000
$8.13
left out
Jason A Keyes
18 Feb 2020
Chief Financial Officer
Sell indirect
5,000
$5.03
$25.14K
Jason A Keyes
21 Jan 2020
Chief Financial Officer
Sell indirect
5,000
$4.41
$22.04K
Jason A Keyes
3 Sep 2019
Chief Financial Officer
Sell indirect
5,000
$3.60
$17.98K
Jason A Keyes
1 Aug 2019
Chief Financial Officer
Sell indirect
5,000
$3.99
$19.94K

What was left out

Form 4 filings counted 157
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 20
Sales at will 17
Transactions with no price 1
Shares from compensation/vesting 1,297,109
Sales filed before the plan box existed 15
History held since 16 Oct 2018